Justin R Ergler
Director of Alternative Fee Intelligence and Analytics
GlaxoSmithKline

Justin works with in-house counsel and law firms to develop non-hourly, value-based Alternative Fee Arrangements for GSK Legal engagements worldwide.  In addition to achieving the goal of “killing of the billable hour”, the value-based compensation models are designed to strengthen partnerships with key firms via risk/reward-sharing incentives.  

Justin is also leading an initiative to develop ROI-style metrics that quantify and capture the value delivered to GSK by successful engagements with outside counsel.  These metrics will give the corporate legal function a finance-based performance metric which showcases actual value as opposed to the traditional financial metrics of cost savings and/or reduction in overall legal spend financial metrics used today. 

The success of these two initiatives will allow GSK to achieve their goal of true value-based arrangements by credibly linking fees with actual value delivered to the company through excellent representations by outside counsel.

Justin holds a Business degree from the University of North Carolina at Chapel Hill and is a veteran of the United States Army's 3rd Infantry Division.  

Sessions I'm Presenting